![Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/21aefd8d-1880-42db-8338-92a386a5842f/gr1.jpg)
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
![Covid-19 vaccine booster effectiveness wanes after four months but still offers protection, study finds | CNN Covid-19 vaccine booster effectiveness wanes after four months but still offers protection, study finds | CNN](https://media.cnn.com/api/v1/images/stellar/prod/220207152234-pfizer-booster-dose-japan-0120.jpg?q=h_1334,w_2000,x_0,y_0)
Covid-19 vaccine booster effectiveness wanes after four months but still offers protection, study finds | CNN
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![Comparative Effectiveness of Pfizer and Moderna COVID-19 Vaccines for Boosting | Bennett Institute for Applied Data Science Comparative Effectiveness of Pfizer and Moderna COVID-19 Vaccines for Boosting | Bennett Institute for Applied Data Science](https://www.bennett.ox.ac.uk/blog/2023/04/comparative-effectiveness-of-pfizer-and-moderna-covid-19-vaccines-for-boosting/parang-mehta-r2fqXao_z70-unsplash_hu3d03a01dcc18bc5be0e67db3d8d209a6_1606091_1238x743_fill_q60_box_center.jpg)
Comparative Effectiveness of Pfizer and Moderna COVID-19 Vaccines for Boosting | Bennett Institute for Applied Data Science
![Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X21016406-gr1.jpg)
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
![Khairy Jamaluddin 🇲🇾🌺 on X: "Real world data from Chile has shown significant increase in vaccine effectiveness after a booster for people who took Sinovac for their primary series. Biggest boost came Khairy Jamaluddin 🇲🇾🌺 on X: "Real world data from Chile has shown significant increase in vaccine effectiveness after a booster for people who took Sinovac for their primary series. Biggest boost came](https://pbs.twimg.com/media/FEJA1NUVQAA7egS.jpg)
Khairy Jamaluddin 🇲🇾🌺 on X: "Real world data from Chile has shown significant increase in vaccine effectiveness after a booster for people who took Sinovac for their primary series. Biggest boost came
![Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01699-1/MediaObjects/41591_2022_1699_Fig1_HTML.png)
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine
![Covid-19 booster shots will be available in mid-September, upon FDA approval, for those who got Pfizer and Moderna shots – Kentucky Health News Covid-19 booster shots will be available in mid-September, upon FDA approval, for those who got Pfizer and Moderna shots – Kentucky Health News](https://cidev.uky.edu/kentuckyhealthnews/wp-content/uploads/2021/08/VE-studies-from-CDC-graphic.png)
Covid-19 booster shots will be available in mid-September, upon FDA approval, for those who got Pfizer and Moderna shots – Kentucky Health News
![Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7118a4-F-large.gif?_=74292)
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
![Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet](https://www.thelancet.com/cms/attachment/97d1c5ff-af79-4d10-b5b8-3026a35a572d/gr1_lrg.jpg)
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
![Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01832-0/MediaObjects/41591_2022_1832_Fig1_HTML.png)